arrow
K

Kelly Godby

Ohio State University
H指数:24
被引数:4,105

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multiple Myeloma, Version 5.2026
2026-01-012
PRE
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025

NCCN Guidelines® Insights: 多发性骨髓瘤,版本 1.2025

2025-05-010
PRE
Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapy

为接受治疗的初诊多发性骨髓瘤患者建立可测量的残留病灶轨迹,作为部署T细胞重定向疗法的基准。

2025-04-230
OA
Waldenstro m Macroglobulinemia/ Lymphoplasmacytic Lymphoma, Version 2.2024
2024-01-011
OA
Multiple Myeloma, Version 2.2024
2023-12-0123
OA
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial
2023-11-0145
OAAI
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

三联疗法,移植和维持直到骨髓瘤进展

2022-07-14241
OA
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy

二代测序量化自体造血细胞移植对多发性骨髓瘤四倍体治疗疾病负荷的影响

2022-07-064
PRE